http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2163742-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61c0b38c0948cdbce0b193c5279ab4a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
filingDate 1997-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51dcb4bf9b7fce1cb999d60751721972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e9cdfec7f2260790a00b0799413afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7b21e02c7326eecd4a4946ab168a4e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77284231353f8f86d3b325604c3db15d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f35d87f883ebc59b0e9f45802a64c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5716ba1c91f496a57ffd11d864e0ffb6
publicationDate 2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2163742-T3
titleOfInvention QUINOXALINADIONAS.
abstract THE INVENTION PROVIDES FORMULA (I) COMPOUNDS AND THE PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, IN WHICH R IS A HETEROARILO GROUP WITH A RING OF 5 LINES THAT CONTAIN 3 OR 4 NITROGEN HETEROATOMS, WHICH IS IN THE MIDDLE OF THE MIDDLE A CARBON OR NITROGEN RING OF THE RING, OR IS AN HETEROARILO GROUP WITH A RING OF 6 LINKS CONTAINING BETWEEN 1 AND 3 NITROGEN HETEROATOMS THAT IS JOINED TO THE QUINOXALINDIONA RING THROUGH A CARBON OPPORTUNITY CONDENSED AND OPTIONALLY SUBSTITUTED, INCLUDING IN THE CONDENSED BENZO PORTION, BY MEANS OF 1 OR 2 SUBSTITUTES, SELECTED EACH OF THEM INDEPENDENTLY BETWEEN RENT C SUB, 1 -C 4, ALQUENILO C 2 -C 4, CYCALOQUIL, 7 HYDROXI, ALCOXI C 1 -C 4, OXICICLOALQUILO C 3 -C 7, -COOH, ALCOXICARBONILO C 1 -C 4, CONR 3 R 4, -N 3 R 4, -S (O) P (RENT C 1 -C 4 ), -SO 2 NR 3 R 4, ARI LO, OXIARILO, ARILALCOXI (C 1 -C 4 ) YHET, BEING SUCH A RENT C 1 -C 4 OPTIONALLY REPLACED WITH CIC LOALQUILO C 3 -C 7, HALOGEN, HIDROXI, ALCOXI C 1-C 4, HALOALCOXI (C 1 -C 4), OXICICLOALQUILO C SUB, 3 C 7, C 3 -C 7-CYCALCYL 7 ALCOXI C 1 C4), -COOH, ALCOXI C 1 -C 4 CARBONYL, CONR 3 R 4, -NR 3 R 4, -S (O) P (C 1 -C 4 RENT), - SO 2 (ARILO), SO 2 NR 3 R 4, MOR FOLINO, ARILO, OXIARILO, ARILALCOXI (C 1 -C 4) OR HET, BEING SUCH ALKYLENE C 2 -C 4 OPTIONALLY REPLACED WITH ARILO; R 1 AND R 2 EACH ONE OF THEM IS SELECTED INDEPENDENTLY BETWEEN H, FLUOROUS, CHLORINE, SPRAY, RENT C 1 -C SUB.4 AND HALOALQUILO C 1 -C SUB.4; R 3 AND R 4 EACH ONE OF THEM IS SELECTED INDEPENDENTLY BETWEEN H AND I RENT C 1 C 4 OR, WHEN THEY JOIN, THEY ARE HERE LENO C 5 -C 7; P ES 0, 1 OR 2; TOGETHER WITH THE PREPARATION OF THE COMPOSITIONS THAT CONTAIN THEM, THE USES OF AND THE INTERMEDIATES USED IN THE SYNTHESIS OF SUCH COMPOUNDS. THE COMPOUNDS ARE USEFUL AS ANTAGONISTS OF THE NMDA RECEIVER FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE AND CHRONIC NEUROLOGICAL DISORDERS.
priorityDate 1996-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427267

Total number of triples: 60.